Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

Overview of attention for article published in Liver Transplantation, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 3,803)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 7 news outlets
policy: 1 policy source
twitter: 9 X users
patent: 6 patents

facebook: 1 Facebook page
wikipedia: 3 Wikipedia pages
guideline: 3 clinical guideline sources

Readers on

mendeley: 120 Mendeley

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 46,268 followers.

Open Access UCL Research: Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial https://t.co/E6G5nBhlGl

RT @AASLDtweets: From @LTxJournal: "Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, con…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.